chartexchange

HRGN
HARVARD APPRATS REG TCH
stockOTC

EODNov 18, 2026
1.90USD0.000%(0.00)2,222
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$1.90
Beta
-0.85
52-Week High
$2.46 2026-09-03
52-Week Low
$0.96 2026-01-13
SMA 50
$2.01
SMA 200
$1.74
Avg. Vol 10D
9,075
Avg. Vol 30D
4,071
Avg. Vol 90D
3,001
Relative Vol
0.55
8.63M
HRGN Profile

biostage, inc. (otcqb: bstg) is a pioneering biotechnology company developing bioengineered organ implants to address unmet needs in the treatment of life-threatening cancer, traumas and congenital abnormalities of the esophagus, bronchus and trachea. the company's cellframe™ technology platform is engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. combining a synthetic scaffold with tissue engineering and cell biology, biostage's cellframe™ platform is used to create organ specific cellspan™ implants. the cellspan™ implant is delivered directly to the site where tissue regeneration is needed, and has been designed to promote in situ tissue regeneration by providing both stem cell-derived biological signals, and three-dimensional guidance and support for cell growth differentiation. recent large animal data delivered promising results as cellframe™-based cellspan™ implants applied to the esophagus achieved regener

HRGN Performance
PeriodPriceDateChangeBeta
1W1.982026-11-12-4.04%5.698
1M2.212026-10-19-14.18%-1.872
3M1.522026-08-20+25.08%-2.193
6M1.402026-05-19+35.71%-1.351
1Y1.692025-11-25+12.43%-0.855
2Y2.972024-11-20-36.05%—
5Y4.452023-07-20-57.30%-0.297
HRGN Stock Summary

HARVARD APPRATS REG TCH (OTC:HRGN) stock price today is $1.90, and today's volume is 2,222. HRGN is up 0.000% today. The 30 day average volume is 4,071. HRGN market cap is $27.29M with 14.37M shares outstanding.